Glaucoma, Stem Cells, and Gene Therapy: Where Are We Now?
International Journal of Stem Cells
;
: 119-128, 2017.
Article
in English
| WPRIM
| ID: wpr-80759
ABSTRACT
Glaucoma is the second most common cause of blindness, affecting 70~80 million people around the world. The death of retinal ganglion cells (RGCs) is the main cause of blindness related to this disease. Current therapies do not provide enough protection and regeneration of RGCs. A novel opportunity for treatment of glaucoma is application of technologies related to stem cell and gene therapy. In this perspective we will thus focus on emerging approaches to glaucoma treatment including stem cells and gene therapy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Regeneration
/
Retina
/
Retinal Ganglion Cells
/
Stem Cells
/
Genetic Therapy
/
Glaucoma
/
Blindness
Language:
English
Journal:
International Journal of Stem Cells
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS